v3.26.1
Net Income (Loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income (Loss) per Share

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except for per share data):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Amounts used for basic and diluted per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Agenus Inc. common stockholders

 

$

(604

)

 

$

(28,009

)

 

$

38,567

 

 

$

(53,329

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of Agenus Inc. common shares outstanding - basic

 

 

41,338

 

 

 

28,117

 

 

 

39,649

 

 

 

26,303

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

    Share based compensation awards

 

 

 

 

 

 

 

 

453

 

 

 

 

    Warrants

 

 

 

 

 

 

 

 

21

 

 

 

 

Weighted average number of Agenus Inc. common shares outstanding - diluted

 

 

41,338

 

 

 

28,117

 

 

 

40,123

 

 

 

26,303

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Agenus Inc. per common share:

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

$

(0.01

)

 

$

(1.00

)

 

$

0.97

 

 

$

(2.03

)

    Diluted

 

$

(0.01

)

 

$

(1.00

)

 

$

0.96

 

 

$

(2.03

)

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding The following securities (listed on an as-if-converted-to-Common-Stock basis) have been excluded from the computation of diluted weighted average shares outstanding as of June 30, 2026 and 2025, as they would be anti-dilutive (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Warrants

 

 

1,089

 

 

 

1,032

 

 

 

1,068

 

 

 

1,032

 

Stock options

 

 

8,942

 

 

 

5,242

 

 

 

8,491

 

 

 

5,242

 

Non-vested shares

 

 

11

 

 

 

1,313

 

 

 

9

 

 

 

1,313

 

Series A-1 convertible preferred stock

 

 

17

 

 

 

17

 

 

 

17

 

 

 

17